Activated Bacterial Therapeutic Platform

Optimizing Microbiome Delivery

ABT Platform Pipeline

Advancing Healing Through Microbiome Therapeutics

Scioto Biosciences is a preclinical stage biotech company dedicated to innovative research and discovery in the field of microbiome therapeutics. Our team has developed a proprietary Activated Bacterial Therapeutics (ABT) platform for delivering best-in-class, live therapeutic bacteria to the gut. Our solution is focused on the formation of beneficial biofilms that have the potential to advance healing for various diseases associated with the GI tract, Oncology and CNS indications.

About Us
Healing Through Microbiome Therapeutics